Surgical and clinical outcomes with neoadjuvant atezolizumab in resectable stage IB-IIIB NSCLC: LCMC3 trial primary analysis Meeting Abstract
| Authors: | Lee, J.; Chaft, J.; Nicholas, A.; Patterson, A.; Waqar, S.; Toloza, E.; Haura, E.; Raz, D.; Reckamp, K.; Merritt, R.; Owen, D.; Finley, D.; McNamee, C.; Blasberg, J.; Garon, E.; Mitchell, J.; Doebele, R.; Baciewicz, F.; Nagasaka, M.; Pass, H.; Schulze, K.; Phan, S.; Johnson, A.; Bunn, P.; Johnson, B.; Kris, M.; Kwiatkowski, D.; Wistuba, I.; Carbone, D.; Rusch, V. |
| Abstract Title: | Surgical and clinical outcomes with neoadjuvant atezolizumab in resectable stage IB-IIIB NSCLC: LCMC3 trial primary analysis |
| Meeting Title: | 2020 World Conference on Lung Cancer |
| Keywords: | neoadjuvant; atezolizumab; early stage lung cancer |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 16 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2021 Jan 28-31 |
| Meeting Location: | Singapore |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2021-03-01 |
| Start Page: | S59 |
| End Page: | S61 |
| Language: | English |
| ACCESSION: | WOS:000631349600004 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jtho.2021.01.320 |
| Notes: | Meeting Abstract: PS01.05 -- Due to Covid-19 pandemic, the conference was held virtually -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
